N
Nanobiotix SA
Cambridge, United States
Founded 2003 NASDAQ: NBTX
About
Clinical-stage nanomedicine company developing first-in-class radioenhancers using hafnium oxide nanoparticles
Company Details
- Type
- commercial
- Employees
- 100-200
- Funding
- $300M+
Key Products
- NBTXR3 (Hensify)